These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26168647)

  • 1. [ISRAELI GUIDELINES FOR THE TREATMENT OF HYPERLIPIDEMIA - 2014 UPDATE].
    Bitzur R; Rozenman Y; Vinker S; Dikerl D; Shemesh J; Lahad A; Gavishl D; Harats D; KnobLer H; ; ; ;
    Harefuah; 2015 May; 154(5):330-3, 337-8. PubMed ID: 26168647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New guidelines on treatment of blood cholesterol: too much of a good thing?].
    Lippi G; Mattiuzzi C
    Recenti Prog Med; 2014 Sep; 105(9):317-21. PubMed ID: 25229759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol treatment and changes in guidelines in an academic medical practice.
    Schoen MW; Salas J; Scherrer JF; Buckhold FR
    Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and treatment of atherosclerosis and cardiovascular diseases].
    Knobler H; Bitzur R; Gavish D; Rubinstein A; Henkin Y; Chajek-Shaul T; Harats D
    Harefuah; 2012 May; 151(5):281-8, 319, 318. PubMed ID: 22844732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Balbisi EA
    Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [UPDATED ISRAELI GUIDELINES FOR THE TREATMENT OF DYSLIPIDEMIA 2020].
    Cohen H; Durst R; Avizohar O; Elis A; Arbel Y; Bornstein N; Bachrach R; Bareket R; Gavish D; Tanne D; Lavon E; Zafrir B; Kamari Y; Shechter M; Henkin Y
    Harefuah; 2021 Jan; 160(1):38-44. PubMed ID: 33474877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with statins: lowering of cholesterol or more?].
    Rutishauser J
    Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
    Nicholls SJ; Uno K; Kataoka Y
    Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1383-90. PubMed ID: 22059787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps.
    Lopez-Jimenez F; Simha V; Thomas RJ; Allison TG; Basu A; Fernandes R; Hurst RT; Kopecky SL; Kullo IJ; Mulvagh SL; Thompson WG; Trejo-Gutierrez JF; Wright RS
    Mayo Clin Proc; 2014 Sep; 89(9):1257-78. PubMed ID: 25131697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.
    Harats D; Leibovitz E; Maislos M; Wolfovitz E; Chajek-Shaul T; Leitersdorf E; Gavish D; Gerber Y; Goldbourt U;
    Isr Med Assoc J; 2005 Jun; 7(6):355-9. PubMed ID: 15984375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
    Bárczi G; Merkely B
    Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
    Robinson JG
    Future Cardiol; 2014 Mar; 10(2):149-52. PubMed ID: 24762237
    [No Abstract]   [Full Text] [Related]  

  • 16. Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.
    Gotto AM; Moon JE
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):573-6. PubMed ID: 24819819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the clinical evidence related to early treatment of elevated LDL for cardiovascular primary prevention.
    Sauser K; Levine DA; Hayward RA
    Evid Based Med; 2015 Oct; 20(5):162-9. PubMed ID: 26173413
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2013 American College of Cardiology/American Heart Association guidelines on treating blood cholesterol and assessing cardiovascular risk: a busy practitioner's guide.
    Gupta A; Smith DA
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):869-92. PubMed ID: 25432387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new pooled cohort equations risk calculator.
    Preiss D; Kristensen SL
    Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.